Add this suggestion to a batch that can be applied as a single commit.
This suggestion is invalid because no changes were made to the code.
Suggestions cannot be applied while the pull request is closed.
Suggestions cannot be applied while viewing a subset of changes.
Only one suggestion per line can be applied in a batch.
Add this suggestion to a batch that can be applied as a single commit.
Applying suggestions on deleted lines is not supported.
You must change the existing code in this line in order to create a valid suggestion.
Outdated suggestions cannot be applied.
This suggestion has been applied or marked resolved.
Suggestions cannot be applied from pending reviews.
Suggestions cannot be applied on multi-line comments.
Suggestions cannot be applied while the pull request is queued to merge.
Suggestion cannot be applied right now. Please check back later.
EOD v3.1 Review and Conversion:
After EOD v3.1 has been deployed
AJCC ID [995]: there were changes to the V9 AJCC ID values to match the AJCC's new numbering scheme. Logic provided for those who CANNOT recalculate across their database.
In situ: there were changes to the calculation tables for the Derived EOD 2018 fields in approximately 41 schemas where AJCC does not define Tis. The Derived EOD 2018 N and Derived EOD 2018 M will both be set to 88 for such cases. Logic provided for those who CANNOT recalculate across their database.
Grade: there were changes to the calculation tables for the Derived EOD 2018 Stage Group in 8 schemas where Grade is considered for stage group determination. The calculation no longer prioritizes by timing, but now uses the highest grade captured between Grade Clinical [3843] and Grade Pathological [3844]. Also, for Retroperitoneum and Soft Tissue Trunk and Extremities, the Grade value of ‘H’ was added to the Grade tables in v3.0 but had not been added to the Stage Group calculation tables – this has been corrected. If Derived EOD 2018 Stage Group is collected, it will need to be recalculated.
Grade: Derived Summary Grade [1975] has been defined. This field will be calculated at the central registries for all cases diagnosed 2018 and later. The more severe value from Grade Clinical [3843] and Grade Pathological [3844] will be used. Breast is a special case because behavior affects the priority. If this field is required for your registry:
SEER Site Specific Factor 1 [3700]: the field is changing from a 1 digit fields to a 2 digit field. There is a conversion between the old values and the new.
If Schema ID [3800] = 00071 (Lip), 00072 (Tongue Anterior), 00073 (Gum), 00074 (Floor of Mouth), 00075 (Palate Hard), 00076 (Buccal Mucosa), 00077 (Mouth Other), 00112 (Hypopharynx), 00100 (Oropharynx HPV-Mediated (p16+)), 00111 (Oropharynx (p16-))
If Schema ID [3800] = 00071 (Lip), 00072 (Tongue Anterior), 00073 (Gum), 00074 (Floor of Mouth), 00075 (Palate Hard), 00076 (Buccal Mucosa), 00077 (Mouth Other), 00112 (Hypopharynx)
Else If Schema ID [3800] = 00100 (Oropharynx HPV-Mediated (p16+)) Schema Discriminator 2 [3927] must be 2 for this schema
Else If Schema ID [3800] = 00111 (Oropharynx (p16-)) Schema Discriminator 2 [3927] must be 1 or 9 for this schema
EOD v3.1 changes:
EOD and SS2018 - includes changes to schema definitions, EOD fields and SS2018
General Changes
LVI: LVI was removed from all schemas. The values shown had been limited to those applicable to the schema but a single lookup (available in NAACCR) can be used.
Version 9 Updated Diseases: AJCC released the 9th revision of the NET (excluding Adrenal Gland) and Vulva diseases which will be effective for cases diagnosed 1/1/2024 or later. There are now 2 schemas for each.
Version 9 Updates IDs: AJCC ID [#995] has been revised by the AJCC. This affects the AJCC IDs for Cervix Uteri V9, Appendix V9, Anus V9, Brain and Spinal Cord Other V9, and Brain and Spinal Cord Medulloblastoma V9. Please see the AJCC DLL's change log for more information. (See 'EOD v3.1 Review and Conversion')
In Situ Calculation: For those schemas where AJCC does not define Tis but EOD Primary Tumor includes 000 for In situ, the Derived EOD 2018 T was being set to 88, but the Derived EOD 2018 N and Derived EOD 2018 M were being set based on the normal logic for the coded value. New calculation logic has been added to ensure that for these schema, if EOD Primary Tumor is set to 000, all of Derived EOD 2018 T, Derived EOD 2018 N, Derived EOD 2018 M and Derived EOD 2018 Stage Group are set to 88. (See 'EOD v3.1 Review and Conversion')
Bladder
Kidney Parenchyma
Lung
Merkel Cell Skin
NET Pancreas 8th and NET Pancreas V9
Pancreas
Prostate
Soft Tissue Abdomen and Thoracic
Vulva V9
SSDI and Grade - NAACCR is the custodian of these fields, changes are listed here for convenience. See Change Log on https://apps.naaccr.org/ssdi/list/ for complete information.
General Changes
Anus V9, Cervix V9
Breast
Brain V9
Brain V9, CNS Other V9
Buccal Mucosa, Floor of Mouth, Gum, Hypopharynx, Lip, Mouth Other, Oropharynx HPV-Mediated (p16+), Oropharynx (p16-), Palate Hard, Tongue Anterior
Cervix 8th, Vagina, Vulva 8th, Vulva V9
Cervix Sarcoma, Corpus Adenosarcoma, Corpus Carcinoma and Carcinosarcoma, Corpus Sarcoma
Colon and Rectum
Corpus Carcinoma and Carcinosarcoma
Kidney Parenchyma
Melanoma Skin
Soft Tissue Abdomen and Thoracic, Soft Tissue Trunk and Extremities
Vulva V9